PBLS
insider transactionsParabilis Medicines, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Cluster buy signal: Multiple insiders at the same company buying around the same time — often a stronger signal than a single buy. 2 different insiders made open-market purchases in the last 365 days, totalling $25.7M.
Net shares · 365d
+5.0M
5.0M buy · 0 sell
Net value · 365d
$25.7M
$25.7M in · $0 out
Sentiment · 365d
Net buying
100% buying · 0% selling
Open-market trades · 365d
8
5.0M buy · 0 sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
James E Flynn / DEERFIELD MANAGEMENT COMPANY, L.P.
Director, 10% Owner
$0
3.4K sh
Own New
-
Buy·P
Director
$110.1K
4.1K sh · $27.10
Own +16%
-
Buy·P
Director
$130.0K
5.0K sh · $26.00
Own +24%
-
Buy·P
Director
$233.4K
8.4K sh · $27.67
Own +67%
-
Exercise·C
-
Exercise·C
-
Exercise·C
-
Exercise·C
-
Exercise·C
-
Exercise·C
-
Exercise·C
-
Exercise·C
-
Buy·P
Director
$250.0K
12.5K sh · $20.00
Own New
-
Exercise·C
Director
—
8.1K sh
Own New
-
Exercise·C
Director
—
3.7K sh
Own New
-
Exercise·C
Director
—
5.3K sh
Own New
-
Exercise·C
Director
—
5.3K sh
Own +56%
-
Exercise·C
Director
—
3.9K sh
Own +70%
-
Exercise·C
Director
—
5.5K sh
Own New
-
Grant·A
Director
$0
9.2K sh
Own New
-
Grant·A
Director
$0
20.2K sh
Own New
-
Grant·A
Director
$0
20.2K sh
Own New
-
Grant·A
Director
$0
20.2K sh
Own New
-
Grant·A
Director
$0
39.8K sh
Own New
-
Grant·A
Director
$0
20.2K sh
Own New
-
Grant·A
Director
$0
20.2K sh
Own New
-
Grant·A
James E Flynn / DEERFIELD MANAGEMENT COMPANY, L.P.
Director, 10% Owner
$0
55.1K sh
Own New
-
Buy·P
$10.0M
2.0M sh · $5.00
Own +48%
-
Buy·P
$4.2M
832.0K sh · $5.00
Own +11%
-
Buy·P
$5.4M
1.1M sh · $5.00
Own +11%
-
Buy·P
$5.4M
1.1M sh · $5.00
Own +11%
About PBLS insider trading
This page tracks insider transactions for Parabilis Medicines, Inc. (PBLS) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.